The PE Ratio as of May 2025 (TTM) for Iterum Therapeutics plc (ITRM) is -0.80

According to Iterum Therapeutics plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.80. This represents a change of -20.45% compared to the average of -1.01 of the last 4 quarters.

Iterum Therapeutics plc (ITRM) Historical PE Ratio (quarterly & annually)

How has ITRM PE Ratio performed in the past?

The mean historical PE Ratio of Iterum Therapeutics plc over the last ten years is -4.48. The current -0.80 PE Ratio has changed 1.69% with respect to the historical average. Over the past ten years (40 quarters), ITRM's PE Ratio was at its highest in in the June 2021 quarter at 13.33. The PE Ratio was at its lowest in in the March 2022 quarter at -4.64.

Iterum Therapeutics plc (ITRM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Iterum Therapeutics plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Iterum Therapeutics plc (ITRM) Average PE Ratio

How has ITRM PE Ratio performed in the past?

The current PE Ratio of Iterum Therapeutics plc (ITRM) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Iterum Therapeutics plc (ITRM) PE Ratio vs. Peers

How is ITRM’s PE Ratio compared to its peers?

Iterum Therapeutics plc’s PE Ratio is less than Onconova Therapeutics, Inc. (-0.01), greater than Adial Pharmaceuticals, Inc. (-0.86), greater than Diffusion Pharmaceuticals Inc. (-4.86), greater than Aeterna Zentaris Inc. (-1.47), less than Tonix Pharmaceuticals Holding Corp. (-0.00), less than Fortress Biotech, Inc. (-0.69), less than Eyenovia, Inc. (-0.03), less than Ocuphire Pharma, Inc. (-0.52), less than Galera Therapeutics, Inc. (-0.07), greater than Citius Pharmaceuticals, Inc. (-3.42), less than Jaguar Health, Inc. (-0.06), greater than Acasti Pharma Inc. (-2.77), less than iBio, Inc. (-0.37), less than First Wave BioPharma, Inc. (-0.11), less than Dermata Therapeutics, Inc. (-0.10), less than Revelation Biosciences, Inc. (-0.08), less than Panbela Therapeutics, Inc. (-0.04), less than ContraFect Corporation (-0.00), less than Verrica Pharmaceuticals Inc. (-0.45), greater than Hoth Therapeutics, Inc. (-0.83), less than Vincerx Pharma, Inc. (-0.02),

Build a custom stock screener for Iterum Therapeutics plc (ITRM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Iterum Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Iterum Therapeutics plc (ITRM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Iterum Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.